OSCR logo

Oscar Health (OSCR) EBITDA

annual EBITDA:

$89.31M+$301.31M(+142.12%)
December 31, 2024

Summary

  • As of today (May 29, 2025), OSCR annual EBITDA is $89.31 million, with the most recent change of +$301.31 million (+142.12%) on December 31, 2024.
  • During the last 3 years, OSCR annual EBITDA has risen by +$640.56 million (+116.20%).
  • OSCR annual EBITDA is now at all-time high.

Performance

1-year change

+142.12%

3-year change

+116.2%

5-year change

+135.37%

15-year change

+135.37%

OSCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

87.27%
OSCR annual EBITDA is higher than 87.27% of companies in Healthcare sector

Range

All-time high

$89.31M
OSCR annual EBITDA is currently at an all-time high

3-year low

-$572.17M

Earnings dates

Last annual earnings report date

Dec 31, 2024
OSCR previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
OSCR next annual earnings announcement has not yet been scheduled

OtherOSCRincome statement metrics

Annual revenue

$9.18B
OSCR annual revenue is $9.18 billion

annual net income

$25.43M
OSCR annual net profit is $25.43 million

annual EBIT

$57.16M
OSCR annual earnings before interest & taxes is $57.16 million

Annual EPS

$0.10
OSCR annual earnings per share is $0.10

quarterly EBITDA:

$300.94M+$439.37M(+317.39%)
March 31, 2025

Summary

  • As of today (May 29, 2025), OSCR quarterly EBITDA is $300.94 million, with the most recent change of +$439.37 million (+317.39%) on March 31, 2025.
  • Over the past year, OSCR quarterly EBITDA has increased by +$108.74 million (+56.58%).
  • OSCR quarterly EBITDA is now at all-time high.

Performance

3-month change

+317.39%

1-year change

+56.58%

3-year change

+543.97%

5-year change

+422.19%

OSCR quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

94.43%
OSCR quarterly EBITDA is higher than 94.43% of companies in Healthcare sector

Range

All-time high

$300.94M
OSCR quarterly EBITDA is currently at an all-time high

3-year low

-$217.41M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
OSCR previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 7, 2025
OSCR next earnings announcement is scheduled for Aug 7, 2025

OtherOSCRincome statement metrics

Quarterly revenue

$3.05B
OSCR quarterly revenue is $3.05 billion

quarterly net income

$275.27M
OSCR quarterly net profit is $275.27 million

quarterly EBIT

$294.20M
OSCR quarterly earnings before interest & taxes is $294.20 million

Quarterly EPS

$0.92
OSCR quarterly earnings per share is $0.92

TTM EBITDA:

$198.05M+$108.74M(+121.77%)
March 31, 2025

Summary

  • As of today (May 29, 2025), OSCR TTM EBITDA is $198.05 million, with the most recent change of +$108.74 million (+121.77%) on March 31, 2025.
  • Over the past year, OSCR TTM EBITDA has increased by +$191.33 million (+2847.16%).
  • OSCR TTM EBITDA is now at all-time high.

Performance

3-month change

+121.77%

1-year change

+2847.16%

3-year change

+136.8%

5-year change

+312.03%

OSCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

88.26%
OSCR TTM EBITDA is higher than 88.26% of companies in Healthcare sector

Range

All-time high

$198.05M
OSCR TTM EBITDA is currently at an all-time high

3-year low

-$572.17M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
OSCR previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 7, 2025
OSCR next earnings announcement is scheduled for Aug 7, 2025

OtherOSCRincome statement metrics

TTM revenue

$10.08B
OSCR TTM revenue is $10.08 billion

TTM net income

$123.33M
OSCR TTM net profit is $123.33 million

TTM EBIT

$166.99M
OSCR TTM earnings before interest & taxes is $166.99 million

TTM EPS

$0.28
OSCR TTM earnings per share is $0.28

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$89.31M
OSCR annual EBITDA is $89.31 million

annual net income

$25.43M
OSCR annual net profit is $25.43 million

annual interest expense

$23.73M
OSCR annual interest expense is $23.73 million

annual income tax

$7.30M
OSCR annual income tax is $7.30 million

annual D&A

$32.15M
OSCR annual depreciation & amortization is $32.15 million

OSCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+142.1%+56.6%+2847.2%
3 y3 years+116.2%+544.0%+136.8%
5 y5 years+135.4%+422.2%+312.0%

OSCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+115.6%at high+238.4%at high+134.6%
5 y5-yearat high+115.6%at high+238.4%at high+134.6%
alltimeall timeat high+115.6%at high+238.4%at high+134.6%

OSCR EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$300.94M(-317.4%)
$198.05M(+121.8%)
Dec 2024
$89.31M(-142.1%)
-$138.43M(+255.0%)
$89.31M(-1.9%)
Sep 2024
-
-$39.00M(-152.3%)
$91.05M(+13.0%)
Jun 2024
-
$74.54M(-61.2%)
$80.58M(+1099.1%)
Mar 2024
-
$192.19M(-240.6%)
$6.72M(-103.2%)
Dec 2023
-$212.00M(-62.9%)
-$136.69M(+176.3%)
-$212.00M(-27.6%)
Sep 2023
-
-$49.47M(-7363.9%)
-$292.72M(-31.6%)
Jun 2023
-
$681.00K(-102.6%)
-$428.23M(-19.3%)
Mar 2023
-
-$26.53M(-87.8%)
-$530.92M(-7.2%)
Dec 2022
-$572.17M
-$217.41M(+17.5%)
-$572.17M(+4.4%)
Sep 2022
-
-$184.98M(+81.3%)
-$548.25M(-4.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$102.00M(+50.5%)
-$571.31M(+6.1%)
Mar 2022
-
-$67.78M(-65.0%)
-$538.22M(-2.4%)
Dec 2021
-$551.25M(+41.0%)
-$193.49M(-7.0%)
-$551.25M(+1.8%)
Sep 2021
-
-$208.03M(+201.9%)
-$541.31M(+31.9%)
Jun 2021
-
-$68.92M(-14.7%)
-$410.48M(+8.5%)
Mar 2021
-
-$80.82M(-56.0%)
-$378.39M(-3.2%)
Dec 2020
-$390.98M(+54.9%)
-$183.54M(+137.7%)
-$390.98M(+88.5%)
Sep 2020
-
-$77.20M(+109.6%)
-$207.44M(+59.3%)
Jun 2020
-
-$36.83M(-60.6%)
-$130.23M(+39.4%)
Mar 2020
-
-$93.40M
-$93.40M
Dec 2019
-$252.49M
-
-

FAQ

  • What is Oscar Health annual EBITDA?
  • What is the all time high annual EBITDA for Oscar Health?
  • What is Oscar Health annual EBITDA year-on-year change?
  • What is Oscar Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Oscar Health?
  • What is Oscar Health quarterly EBITDA year-on-year change?
  • What is Oscar Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Oscar Health?
  • What is Oscar Health TTM EBITDA year-on-year change?

What is Oscar Health annual EBITDA?

The current annual EBITDA of OSCR is $89.31M

What is the all time high annual EBITDA for Oscar Health?

Oscar Health all-time high annual EBITDA is $89.31M

What is Oscar Health annual EBITDA year-on-year change?

Over the past year, OSCR annual EBITDA has changed by +$301.31M (+142.12%)

What is Oscar Health quarterly EBITDA?

The current quarterly EBITDA of OSCR is $300.94M

What is the all time high quarterly EBITDA for Oscar Health?

Oscar Health all-time high quarterly EBITDA is $300.94M

What is Oscar Health quarterly EBITDA year-on-year change?

Over the past year, OSCR quarterly EBITDA has changed by +$108.74M (+56.58%)

What is Oscar Health TTM EBITDA?

The current TTM EBITDA of OSCR is $198.05M

What is the all time high TTM EBITDA for Oscar Health?

Oscar Health all-time high TTM EBITDA is $198.05M

What is Oscar Health TTM EBITDA year-on-year change?

Over the past year, OSCR TTM EBITDA has changed by +$191.33M (+2847.16%)
On this page